Brief: China Pharma Holdings Q2 loss per share $0.06
12/08/2016 11:00
Aug 12 (Reuters) - China Pharma Holdings Inc CPHI.A :
* China Pharma Holdings Inc reports second quarter financial
results
* Q2 revenue fell 37.6 percent to $3.5 million
* Q2 loss per share $0.06
* Company recognized an impairment loss for advance payments
made to the laboratories in amount of $822,539 during Q2
* During Q2, co reviewed contracts relating to advances made
for purchases of intangible assets with independent laboratories
* Following review, co determined two advance payments made
by co for two formulas to two independent laboratories were
impaired
Source text for Eikon: ID:nPn8ctDFka
Further company coverage: CPHI.A
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split